Yu Jeffrey

Jeffrey Yu, Chief Medical Officer of Onemednet Corp (ONMD), has demonstrated a consistent pattern of accumulating shares in the company, with no recorded sales across 68 transactions totaling nearly $2.96 million in buy activity. His most significant purchases occurred in mid-2025, including a $1.3 million acquisition on June 19 and a $546,367 purchase two days prior, followed by a $700,000 transaction on June 20. The activity suggests a strong conviction in ONMD, with Yu continuing to build his position through smaller purchases in subsequent months—notably $119,611 on August 26 and a series of acquisitions ranging from $380 to $17,544 between late August and September 2025. Yu’s transactions are exclusively buy-side, with recent filings showing 20 additional purchases and zero sales. While some filings indicate acquisitions of derivative securities (code "A") with no disclosed dollar value—such as those on November 24 and 26, 2025—the bulk of his activity involves open-market purchases (code "P"). The absence of any sell transactions, combined with sustained buying at varying price points, underscores a long-term accumulation strategy rather than short-term trading. Given the scale and persistence of these purchases, Yu’s position in ONMD reflects a significant financial commitment to the company.